Elanco Animal Health Incorporated Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 56 rows, 56 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-07-01: Reporting owner Kinard David S; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-03-01: Reporting owner Modi Rajeev A.; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-03-01: Reporting owner Simmons Jeffrey N; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-03-01: Reporting owner Correia de Simas Jose Manuel; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
ELAN insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | Kinard David S Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,620 25,620 owned after | $24.09 exercise price | $24.09 | 2026-07-02 |
| 2026-03-01 | Modi Rajeev A. Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,025 29,025 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | Simmons Jeffrey N Director, Officer (PRESIDENT, CEO AND DIRECTOR) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +243,809 243,809 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | Correia de Simas Jose Manuel Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,220 23,220 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | Cabral Ramiro Martin Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,570 42,570 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | McArdle Grace Officer (EVP, MANUFACTURING AND QUALITY) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,025 29,025 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | Kinard David S Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,350 19,350 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | VanHimbergen Robert M Officer (EVP and CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,375 48,375 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | O'Neill Shiv Officer (GC AND CORP SEC) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,993 29,993 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | de Brabander Ellen Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,819 51,819 owned after | $26.40 exercise price | $26.40 | 2026-03-03 |
| 2026-03-01 | Bettington Timothy J Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,350 19,350 owned after | $24.60 exercise price | $26.40 | 2026-03-03 |
| 2025-10-01 | VanHimbergen Robert M Officer (EVP and CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +53,869 53,869 owned after | $20.80 exercise price | $20.80 | 2025-10-03 |
| 2025-03-03 | Correia de Simas Jose Manuel Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +46,383 46,383 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | YOUNG TODD S. Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +134,509 134,509 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | de Brabander Ellen Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,123 106,123 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | Bettington Timothy J Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,936 64,936 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | Simmons Jeffrey N Director, Officer (PRESIDENT, CEO AND DIRECTOR) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +556,587 556,587 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | Modi Rajeev A. Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,297 60,297 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | O'Neill Shiv Officer (GC AND CORP SEC) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,936 64,936 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | Cabral Ramiro Martin Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +92,765 92,765 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | Kinard David S Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +46,383 46,383 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2025-03-03 | McArdle Grace Officer (EVP, MANUFACTURING AND QUALITY) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +59,138 59,138 owned after | $11.31 exercise price | $11.31 | 2025-03-05 |
| 2024-03-01 | YOUNG TODD S. Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +95,749 95,749 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | O'Neill Shiv Officer (GC AND CORP SEC) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,014 34,014 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | Bettington Timothy J Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,620 47,620 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | Cabral Ramiro Martin Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +61,735 61,735 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | Simmons Jeffrey N Director, Officer (PRESIDENT, CEO AND DIRECTOR) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +408,164 408,164 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | Modi Rajeev A. Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,858 42,858 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | McArdle Grace Officer (EVP, MANUFACTURING AND QUALITY) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,953 30,953 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | Kinard David S Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,014 34,014 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | de Brabander Ellen Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,456 69,456 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2024-03-01 | Correia de Simas Jose Manuel Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,109 22,109 owned after | $16.03 exercise price | $16.03 | 2024-03-05 |
| 2023-03-01 | Simmons Jeffrey N Director, Officer (PRESIDENT, CEO AND DIRECTOR) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +567,952 567,952 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | YOUNG TODD S. Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +132,607 132,607 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | Urbanek David Alan Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,700 60,700 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | Kinard David S Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,863 50,863 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | Cabral Ramiro Martin Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +86,207 86,207 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | Kirberger Marcela A. Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +76,065 76,065 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | de Brabander Ellen Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +103,550 103,550 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | Correia de Simas Jose Manuel Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,962 32,962 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2023-03-01 | Modi Rajeev A. Officer (SEE REMARKS) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +53,246 53,246 owned after | $11.26 exercise price | $11.26 | 2023-03-03 |
| 2022-03-01 | YOUNG TODD S. Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,622 57,622 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | Cabral Ramiro Martin Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,747 33,747 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | Correia de Simas Jose Manuel Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,614 13,614 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | Simmons Jeffrey N Director, Officer (PRESIDENT, CEO AND DIRECTOR) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +234,160 234,160 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | Kinard David S Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,026 23,026 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | Kirberger Marcela A. Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,123 28,123 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | Urbanek David Alan Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,480 27,480 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2022-03-01 | de Brabander Ellen Officer (SEE REMARKS) | 4 | Employee Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,522 38,522 owned after | $28.94 exercise price | $28.94 | 2022-03-03 |
| 2018-10-20 | Schacht Aaron L Officer (See Remarks) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,086 21,086 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
| 2018-10-20 | Urbanek David Alan Officer (See Remarks) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,086 21,086 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
| 2018-10-20 | Kinard David S Officer (See Remarks) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,086 21,086 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
| 2018-10-20 | Cabral Ramiro Martin Officer (See Remarks) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,086 21,086 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
| 2018-10-20 | LIN SARENA S Officer (See Remarks) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,086 21,086 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
| 2018-10-20 | Hicks Michael-Bryant Officer (See Remarks) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,383 29,383 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
| 2018-10-20 | Simmons Jeffrey N Director, Officer (Pres., Chief Executive Officer) | 4 | Non-Qualified Stock Option (Right-to-Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109,642 109,642 owned after | $31.61 exercise price | $31.61 | 2018-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |